Article · 2021
Editor
James A Radosevich
Professor, University of Illinois, USA
About
As published by the journal they serve.
Dr. James A Radosevich is a Professor in the School of Dental Medicine at the University of Illinois at Chicago (UIC). From 1983 to 2004 he was an Assistant/Associate Professor and a Certified Clinical Investigator (ICH) at Northwestern University Medical School. He has consulted for numerous companies over the last thirty years, received numerous national grants/awards, and been involved in all aspects of drug development and clinical trials. Dr. Radosevich has been part of six start-up biotechnology/medical companies over the past thirty years and has a history of consistently beating performance milestones. He has held the positions of President, CEO, Chief Scientific Officer, and was the founder for five of these companies. Dr. Radosevich earned a B.S. degree in Biology at Bradley University in Peoria, Illinois in 1978 and a Ph.D. in Experimental Pathology at UIC in 1983. He completed his postdoctoral training at Northwestern University in Tumor Cell Biology, where he established his expertise in immune recognition, immune response, and various molecular and biochemical approaches in understanding the morphology, physiology, and cell biology of human cancer. He has edited three books, and has over four hundred published scientific papers, book chapters and abstracts, as well as 12 patents.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Cancer Clinical TrialsEditor
- Journal of Cancer Clinical TrialsEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2016
Head and neck (H&N) squamous cell cancer adapted to high levels of nitric oxide (NO) causes down regulation of condensin complex I protein in (SCC)
Article · 2016
Upregulation of JUN, FOS & AP1 in head and neck cancer cells upon exposure to high nitric acid (NO) environment
Article · 2016
High nitric oxide-adapted breast cancer cell lines showed down-regulation in cell division cycle protein 27 (CDC27)
Article · 2016
Tumor cells adapted to high nitric oxide ensure survival by up or down regulating specific genes within the apoptosis pathway
Article · 2016
Increased Nitric Oxide (NO) exposure in pseudogenes may play a role in cancer stem cell formation
Article · 2016
In Adenocarcinomas (ACs) high Nitric Oxide (HNO) leads to adaptation of Tumor Stem Cell (TSC)
Article · 2016
Exposure to high levels of Nitric Oxide (NO) showed transmembrane Glycoprotein NMB (GPNMB) over expression in Head & Neck (H&N) Squamous Cell Carcinomas (SCC)
Article · 2016
High nitric oxide levels in head and neck Squamous Cell Carcinomas (SCC) has shown down regulation of Cadherin Type-1 (CDH1) gene
Article · 2016
High nitric oxide exposure causes Upregulation of JUN, FOS & AP1 and may play a role in cancer stem cell formation by pseudogenes expression
Article · 2016
Exposure to high levels of Nitric Oxide (NO) showed transmembrane glycoprotein NMB (GPNMB) over expression and Cadherin-1, Type-1 (CDH1) downregulation, in head and neck Squamous Cell Carcinomas (SCC)
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
